NewEdge Advisors’s Johnson & Johnson JNJ Stock Holding History

NewEdge Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$217M	Sell	888,033 -16,441	-2%	-$3.83M	0.78%	19
2025 Q4	$187M	Buy	904,474 +531,106	+142%	+$105M	0.68%	25
2025 Q3	$69.2M	Buy	373,368 +28,459	+8%	+$4.88M	0.31%	60
2025 Q2	$52.7M	Buy	344,909 +11,088	+3%	+$1.7M	0.27%	71
2025 Q1	$55.4M	Buy	333,821 +38,425	+13%	+$6.01M	0.33%	61
2024 Q4	$42.7M	Buy	295,396 +14,659	+5%	+$2.27M	0.26%	76
2024 Q3	$45.5M	Buy	280,737 +12,217	+5%	+$1.95M	0.3%	70
2024 Q2	$39.2M	Buy	268,520 +27,704	+12%	+$4.12M	0.29%	73
2024 Q1	$38.1M	Sell	240,816 -5,767	-2%	-$918K	0.33%	60
2023 Q4	$39M	Buy	246,583 +1,770	+0.7%	+$271K	0.37%	59
2023 Q3	$38.1M	Buy	244,813 +3,138	+1%	+$518K	0.42%	53
2023 Q2	$40M	Buy	241,675 +3,756	+2%	+$606K	0.45%	49
2023 Q1	$37.2M	Buy	237,919 +7,286	+3%	+$1.18M	0.46%	50
2022 Q4	$25M	Buy	230,633 +34,869	+18%	+$6.02M	0.68%	27
2022 Q3	$32M	Sell	195,764 -3,454	-2%	-$584K	0.53%	41
2022 Q2	$35.4M	Buy	199,218 +49,094	+33%	+$8.75M	0.59%	28
2022 Q1	$26.6M	Buy	150,124 +1,255	+0.8%	+$214K	0.43%	57
2021 Q4	$25.5M	Buy	148,869 +69,590	+88%	+$11.4M	0.38%	59
2021 Q3	$12.8M	Sell	79,279 -4,746	-6%	-$810K	0.32%	78
2021 Q2	$13.8M	Sell	84,025 -110,955	-57%	-$18.4M	0.37%	61
2021 Q1	$32M	Buy	194,980 +122,497	+169%	+$19.8M	0.95%	15
2020 Q4	$11.4M	Sell	72,483 -44,168	-38%	-$6.52M	0.37%	63
2020 Q3	$17.4M	Buy	116,651 +5,467	+5%	+$809K	0.6%	40
2020 Q2	$15.6M	Buy	111,184 +27,632	+33%	+$4.03M	0.61%	44
2020 Q1	$11M	Buy	83,552 +11,293	+16%	+$1.6M	0.53%	52
2019 Q4	$10.5M	Sell	72,259 -716	-1%	-$97.1K	0.42%	57
2019 Q3	$9.4M	Buy	72,975 +25,579	+54%	+$3.37M	0.42%	66
2019 Q2	$6.6M	Buy	47,396 +787	+2%	+$109K	0.4%	64
2019 Q1	$6.51M	Buy	46,609 +1,709	+4%	+$229K	0.42%	67
2018 Q4	$5.79K	Sell	44,900 -4,412	-9%	-$615K	0.37%	66
2018 Q3	$6.81M	Buy	49,312 +315	+0.6%	+$41.9K	0.52%	51
2018 Q2	$5.96K	Buy	48,997 +6,709	+16%	+$837K	0.54%	47
2018 Q1	$5.27M	Buy	42,288 +2,856	+7%	+$386K	0.6%	46
2017 Q4	$5.59M	Sell	39,432 -343	-0.9%	-$47.8K	0.76%	40
2017 Q3	$5.31M	Buy	39,775 +3,975	+11%	+$527K	0.82%	37
2017 Q2	$4.71M	Buy	35,800 +5,064	+16%	+$646K	0.81%	40
2017 Q1	$3.82M	Sell	30,736 -2,032	-6%	-$243K	0.87%	40
2016 Q4	$3.77M	Buy	32,768 +4,549	+16%	+$525K	1.04%	33
2016 Q3	$3.33M	Buy	28,219 +12,586	+81%	+$1.53M	1.05%	41
2016 Q2	$1.89M	Buy	+15,633	New	+$1.78M	0.78%	38
2015 Q4	–	Sell	-7,721	Closed	-$721K	–	59
2015 Q3	$721K	Buy	7,721 +365	+5%	+$35.3K	0.78%	39
2015 Q2	$717K	Buy	7,356 +166	+2%	+$16.6K	0.61%	48
2015 Q1	$723K	Buy	7,190 +315	+5%	+$32K	0.51%	54
2014 Q4	$719K	Buy	+6,875	New	+$725K	0.56%	48

Other funds holding JNJ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NewEdge Advisors's JNJ Position: Q1 2026 in Review

NewEdge Advisors reduced its Johnson & Johnson (JNJ) stake by 1.8% in Q1 2026, selling an estimated $3.83M and leaving 888,033 shares worth $217M. The position accounts for 0.78% of the portfolio, ranked #19.

NewEdge Advisors first reported a position in JNJ in Q4 2014 and has held it in 44 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

NewEdge Advisors held 888,033 shares of Johnson & Johnson worth $217M as of Q1 2026.
NewEdge Advisors sold 16,441 Johnson & Johnson shares in Q1 2026, an estimated $3.83M.
Johnson & Johnson made up 0.78% of NewEdge Advisors's portfolio in Q1 2026, its #19 holding.
NewEdge Advisors first reported a position in Johnson & Johnson in Q4 2014 and has held it in 44 quarters since.
4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.